Total reported value
$697.3M
Reporting period: 2026-03-31 · Number of holdings: 76
Sio Capital Management, LLC disclosed 76 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $697.3M and a quarterly turnover rate of 94.1%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "S"
Trim SNY
-75.3% -$35.5M
Trim ZBH
-83.8% -$29.0M
Trim CELC
-59.4% -$25.5M
Add COR
+534.6% $26.3M
Trim OGN
-74.7% -$19.3M
Add AVR
+187.1% $20.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MMS | Maximus INC | Stock-Industrials | 7.07% | +0.28% | +53.67% | |
| 2 | WAY | Waystar Holding CORP | Stock-Other | 5.68% | +2.52% | +167.59% | |
| 3 | ICLR | ICON Public Limited Company | Stock-Healthcare | 4.86% | +1.21% | +140.84% | |
| 4 | COR | Cencora INC | Stock-Healthcare | 4.55% | +3.71% | +534.55% | |
| 5 | DNTH | Dianthus Therapeutics INC | Stock-Other | 4.45% | +1.37% | -22.01% | |
| 6 | AVR | Anteris Technologies Global | Stock-Other | 4.28% | +2.81% | +187.15% | |
| 7 | CORT | Corcept Therapeutics INC | Stock-Healthcare | 3.90% | +3.90% | NEW | |
| 8 | LIVN | LivaNova PLC | Stock-Other | 3.84% | +0.72% | +30.78% | |
| 9 | TYRA | Tyra Biosciences INC | Stock-Other | 3.33% | +1.15% | +15.10% | |
| 10 | CELC | Celcuity INC | Stock-Other | 3.17% | -4.31% | -59.37% | |
| 11 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 3.05% | +3.05% | NEW | |
| 12 | ANIP | Ani Pharmaceuticals INC | Stock-Other | 2.93% | +1.85% | +204.27% | |
| 13 | ABT | Abbott Laboratories | Stock-Healthcare | 2.75% | +2.75% | NEW | |
| 14 | EMBC | Embecta CORP | Stock-Healthcare | 2.34% | +2.34% | NEW | |
| 15 | ABVX | Abivax Sa-adr | Stock-Other | 2.17% | +1.26% | +214.91% | |
| 16 | VIR | Vir Biotechnology INC | Stock-Other | 1.93% | +1.48% | +213.29% | |
| 17 | HAE | Haemonetics Corp/mass | Stock-Other | 1.78% | +0.61% | +138.23% | |
| 18 | SION | Sionna Therapeutics INC | Stock-Other | 1.69% | +1.69% | NEW | |
| 19 | SNY | Sanofi-adr | Stock-Healthcare | 1.66% | -5.75% | -75.33% | |
| 20 | RAPP | Rapport Therapeutics INC | Stock-Other | 1.65% | +0.77% | +97.99% | |
| 21 | TFX | Teleflex INC | Stock-Healthcare | 1.63% | — | +9.12% | |
| 22 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 1.57% | -0.61% | -16.53% | |
| 23 | CCRN | Cross Country Healthcare INC | Stock-Other | 1.48% | — | +2.77% | |
| 24 | TARA | Protara Therapeutic INC | Stock-Other | 1.47% | — | +14.83% | |
| 25 | GPCR | Structure Therapeutics INC | Stock-Other | 1.45% | -0.75% | +3.77% | |
| 26 | BHVN | Biohaven Ltd. | Stock-Other | 1.41% | -0.80% | -6.49% | |
| 27 | MNPR | Monopar Therapeutics INC | Stock-Other | 1.36% | +1.36% | NEW | |
| 28 | EYPT | Eyepoint INC | Stock-Other | 1.33% | +1.33% | NEW | |
| 29 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.30% | +0.39% | +100.16% | |
| 30 | EWTX | Edgewise Therapeutics INC | Stock-Other | 1.22% | +0.29% | +13.27% | |
| 31 | CMPS | Compass Pathways PLC | Stock-Other | 1.19% | +1.19% | NEW | |
| 32 | OCUL | Ocular Therapeutix INC | Stock-Other | 1.18% | +1.18% | NEW | |
| 33 | AQST | Aquestive Therapeutics INC | Stock-Other | 1.14% | — | +93.63% | |
| 34 | RLMD | Relmada Therapeutics INC | Stock-Other | 0.96% | +0.96% | NEW | |
| 35 | ORKA | Oruka Therapeutics INC | Stock-Other | 0.93% | +0.37% | +12.16% | |
| 36 | ZBIO | Zenas Biopharma INC | Stock-Other | 0.93% | +0.93% | NEW | |
| 37 | DRUG | Bright Minds Biosciences INC | Stock-Other | 0.90% | — | +5.13% | |
| 38 | QDEL | Quidelortho CORP | Stock-Other | 0.85% | +0.85% | NEW | |
| 39 | ZBH | Zimmer Biomet Holdings INC | Stock-Healthcare | 0.81% | -4.64% | -83.76% | |
| 40 | REPL | Replimune Group INC | Stock-Other | 0.79% | +0.79% | NEW | |
| 41 | OGN | Organon & Co | Stock-Healthcare | 0.74% | -3.12% | -74.69% | |
| 42 | OKUR | Onkure Therapeutics Inc-a | Stock-Other | 0.64% | +0.64% | NEW | |
| 43 | IRON | Disc Medicine INC | Stock-Other | 0.60% | — | +13.23% | |
| 44 | PMVP | Pmv Pharmaceuticals INC | Stock-Other | 0.55% | — | +16.69% | |
| 45 | IMNM | Immunome INC | Stock-Other | 0.52% | +0.52% | NEW | |
| 46 | IART | Integra Lifesciences Holding | Stock-Other | 0.52% | +0.52% | NEW | |
| 47 | SVRA | Savara INC | Stock-Other | 0.48% | — | — | |
| 48 | CNC | Centene CORP | Stock-Healthcare | 0.47% | -1.31% | -63.55% | |
| 49 | ✓ | Proqr Thrapeutics N V | Stock-Other | 0.45% | — | -9.68% | |
| 50 | SI | Shoulder Innovations INC | Stock-Other | 0.44% | — | -7.60% |
Performance for Q3 2026
+13.6%
Performance Last 4 Quarters
+86.5%
Based on 76% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 76 | $697.3M | 94 | |
| 2025-12-31 | 68 | $635.7M | 96 | |
| 2025-09-30 | 51 | $395.2M | 100 | |
| 2025-06-30 | 52 | $261.8M | 0 | |
| 2025-03-31 | 54 | $335.8M | 100 | |
| 2024-12-31 | 51 | $355.4M | 0 | |
| 2024-09-30 | 39 | $252.2M | 0 | |
| 2024-06-30 | 48 | $369.5M | 0 | |
| 2024-03-31 | 51 | $335.8M | 0 | |
| 2023-12-31 | 43 | $439.2M | 0 | |
| 2023-09-30 | 52 | $323.1M | 0 | |
| 2023-06-30 | 47 | $393.2M | 0 | |
| 2023-03-31 | 44 | $202.3M | 0 | |
| 2022-12-31 | 47 | $270.4M | 0 | |
| 2022-09-30 | 49 | $314.7M | 0 | |
| 2022-06-30 | 62 | $266.2M | 0 | |
| 2022-03-31 | 66 | $302.3M | 0 | |
| 2021-12-31 | 70 | $331.7M | 0 | |
| 2021-09-30 | 61 | $313.7M | 0 | |
| 2021-06-30 | 74 | $402.3M | 70 | |
| 2021-03-31 | 89 | $492.7M | 71 | |
| 2020-12-31 | 89 | $488.5M | 79 | |
| 2020-09-30 | 89 | $505.0M | 86 | |
| 2020-06-30 | 78 | $342.7M | 94 | |
| 2020-03-31 | 69 | $298.4M | 100 | |
| 2019-12-31 | 69 | $419.8M | 93 | |
| 2019-09-30 | 63 | $310.5M | 100 | |
| 2019-06-30 | 71 | $414.8M | 100 | |
| 2019-03-31 | 70 | $370.4M | 98 | |
| 2018-12-31 | 69 | $274.5M | 100 | |
| 2018-09-30 | 64 | $291.5M | 100 | |
| 2018-06-30 | 49 | $180.9M | 100 | |
| 2018-03-31 | 31 | $166.4M | 100 | |
| 2017-12-31 | 45 | $177.3M | 100 | |
| 2017-09-30 | 54 | $192.7M | 100 | |
| 2017-06-30 | 58 | $210.4M | 92 | |
| 2017-03-31 | 46 | $178.8M | 100 | |
| 2016-12-31 | 43 | $171.4M | 93 | |
| 2016-09-30 | 32 | $145.0M | 91 | |
| 2016-06-30 | 43 | $195.8M | 100 | |
| 2016-03-31 | 42 | $273.2M | 100 | |
| 2015-12-31 | 42 | $225.8M | 100 | |
| 2015-09-30 | 35 | $145.9M | 100 | |
| 2015-06-30 | 39 | $202.4M | 100 | |
| 2015-03-31 | 30 | $175.7M | 100 | |
| 2014-12-31 | 30 | $127.3M | 0 |
Sio Capital Management, LLC's most significant position changes for 2026-03-31: Sold out: THE Cigna Group (CI); Sold out: Rhythm Pharmaceuticals INC (RYTM); New buy: Corcept Therapeutics INC (CORT); Sold out: Kenvue INC (KVUE); New buy: Gsk Plc-spon Adr (GSK).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | COR | Cencora INC | +3.7% | +534.55% | Add |
| 2 | AVR | Anteris Technologies Global | +2.8% | +187.15% | Add |
| 3 | WAY | Waystar Holding CORP | +2.5% | +167.59% | Add |
| 4 | ANIP | Ani Pharmaceuticals INC | +1.9% | +204.27% | Add |
| 5 | VIR | Vir Biotechnology INC | +1.5% | +213.29% | Add |
| 6 | DNTH | Dianthus Therapeutics INC | +1.4% | -22.01% | Trim |
| 7 | ABVX | Abivax Sa-adr | +1.3% | +214.91% | Add |
| 8 | ICLR | ICON Public Limited Company | +1.2% | +140.84% | Add |
| 9 | TYRA | Tyra Biosciences INC | +1.2% | +15.10% | Add |
| 10 | RAPP | Rapport Therapeutics INC | +0.8% | +97.99% | Add |
| 11 | LIVN | LivaNova PLC | +0.7% | +30.78% | Add |
| 12 | HAE | Haemonetics Corp/mass | +0.6% | +138.23% | Add |
| 13 | CRNX | Crinetics Pharmaceuticals In | +0.4% | +100.16% | Add |
| 14 | ORKA | Oruka Therapeutics INC | +0.4% | +12.16% | Add |
| 15 | EWTX | Edgewise Therapeutics INC | +0.3% | +13.27% | Add |
| 16 | MMS | Maximus INC | +0.3% | +53.67% | Add |
| 17 | BMRN | Biomarin Pharmaceutical INC | -0.6% | -16.53% | Trim |
| 18 | GPCR | Structure Therapeutics INC | -0.8% | +3.77% | Add |
| 19 | BHVN | Biohaven Ltd. | -0.8% | -6.49% | Trim |
| 20 | CNC | Centene CORP | -1.3% | -63.55% | Trim |
| 21 | OGN | Organon & Co | -3.1% | -74.69% | Trim |
| 22 | CELC | Celcuity INC | -4.3% | -59.37% | Trim |
| 23 | ZBH | Zimmer Biomet Holdings INC | -4.6% | -83.76% | Trim |
| 24 | SNY | Sanofi-adr | -5.8% | -75.33% | Trim |
| 25 | CI | THE Cigna Group | — | EXIT | Sold out |
| 26 | RYTM | Rhythm Pharmaceuticals INC | — | EXIT | Sold out |
| 27 | CORT | Corcept Therapeutics INC | — | NEW | New buy |
| 28 | KVUE | Kenvue INC | — | EXIT | Sold out |
| 29 | GSK | Gsk Plc-spon Adr | — | NEW | New buy |
| 30 | ABT | Abbott Laboratories | — | NEW | New buy |
| 31 | EMBC | Embecta CORP | — | NEW | New buy |
| 32 | SION | Sionna Therapeutics INC | — | NEW | New buy |
| 33 | BTSG | Brightspring Health Services | — | EXIT | Sold out |
| 34 | CRL | Charles River Laboratories | — | EXIT | Sold out |
| 35 | MNPR | Monopar Therapeutics INC | — | NEW | New buy |
| 36 | EYPT | Eyepoint INC | — | NEW | New buy |
| 37 | CMPS | Compass Pathways PLC | — | NEW | New buy |
| 38 | OCUL | Ocular Therapeutix INC | — | NEW | New buy |
| 39 | RLMD | Relmada Therapeutics INC | — | NEW | New buy |
| 40 | ZBIO | Zenas Biopharma INC | — | NEW | New buy |
| 41 | QDEL | Quidelortho CORP | — | NEW | New buy |
| 42 | REPL | Replimune Group INC | — | NEW | New buy |
| 43 | MCK | Mckesson CORP | — | EXIT | Sold out |
| 44 | OKUR | Onkure Therapeutics Inc-a | — | NEW | New buy |
| 45 | FULC | Fulcrum Therapeutics INC | — | EXIT | Sold out |
| 46 | IMNM | Immunome INC | — | NEW | New buy |
| 47 | IART | Integra Lifesciences Holding | — | NEW | New buy |
| 48 | VTYXUSD | Ventyx Biosciences INC | — | EXIT | Sold out |
| 49 | ALKS | Alkermes plc | — | EXIT | Sold out |
| 50 | IDYA | Ideaya Biosciences INC | — | EXIT | Sold out |
Institutions with a similar AUM
CIK 0001767080
Total reported value
$697.2M
246 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001729869
Total reported value
$697.4M
100 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001542324
Total reported value
$697.1M
199 stks
2026-06-30
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0000740272
Total reported value
$684.3M
101 stks
2026-03-31
1 of the top 5 holdings overlap, including ICON Public Limited Company
CIK 0000790502
Total reported value
$19.6B
547 stks
2024-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Cencora INC
CIK 0000928204
Total reported value
$347.5M
129 stks
2016-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Cencora INC